Literature DB >> 8500902

Immune responses and resistance to Toxoplasma gondii in mice immunized with antigens of the parasite incorporated into immunostimulating complexes.

A Lundén1, K Lövgren, A Uggla, F G Araujo.   

Abstract

Immunostimulating complexes were prepared with antigens extracted from tachyzoites of Toxoplasma gondii and were used to immunize mice. The major antigens incorporated into the immunostimulating complexes were the P30 and P22 antigens and an antigen with an approximate molecular weight of 6,000. Other antigens of molecular weights above 30,000 were also present. High antibody titers to T. gondii antigens and a delayed-type hypersensitivity reaction were noted for the immunized mice. Challenge of these mice with tachyzoites injected interperitoneally or with oocysts administered orally resulted in a statistically significant (P < 0.001) conditional probability of survival compared with that of controls. In contrast, the differences between immunized mice and controls challenged with tissue cysts did not attain statistical significance.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8500902      PMCID: PMC280895          DOI: 10.1128/iai.61.6.2639-2643.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Western blot analysis of the antibody response of patients with AIDS and toxoplasma encephalitis: antigenic diversity among Toxoplasma strains.

Authors:  L M Weiss; S A Udem; H Tanowitz; M Wittner
Journal:  J Infect Dis       Date:  1988-01       Impact factor: 5.226

2.  Dual regulation of resistance against Toxoplasma gondii infection by Lyt-2+ and Lyt-1+, L3T4+ T cells in mice.

Authors:  Y Suzuki; J S Remington
Journal:  J Immunol       Date:  1988-06-01       Impact factor: 5.422

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Cloning, expression, and cDNA sequence of surface antigen P22 from Toxoplasma gondii.

Authors:  J B Prince; K L Auer; J Huskinson; S F Parmley; F G Araujo; J S Remington
Journal:  Mol Biochem Parasitol       Date:  1990-11       Impact factor: 1.759

5.  High antibody responses in rabbits immunized with influenza virus ISCOMs containing a repeated sequence of the Plasmodium falciparum antigen Pf155/RESA.

Authors:  A Sjölander; K Lövgren; S Ståhl; L Aslund; M Hansson; P A Nygren; M Larsson; M Hagstedt; B Wåhlin; K Berzins
Journal:  Vaccine       Date:  1991-06       Impact factor: 3.641

6.  Detection and characterization of membrane antigens of Toxoplasma gondii.

Authors:  E Handman; J W Goding; J S Remington
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

7.  Strain-specific antigens of Toxoplasma gondii.

Authors:  P L Ware; L H Kasper
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

8.  Pathophysiology of toxoplasmosis.

Authors:  J K Frenkel
Journal:  Parasitol Today       Date:  1988-10

9.  Vaccination of sheep with a live incomplete strain (S48) of Toxoplasma gondii and their immunity to challenge when pregnant.

Authors:  D Buxton; K Thomson; S Maley; S Wright; H J Bos
Journal:  Vet Rec       Date:  1991-08-03       Impact factor: 2.695

10.  Antigenic differences between endozoites and cystozoites of Toxoplasma gondii.

Authors:  M N Lunde; L Jacobs
Journal:  J Parasitol       Date:  1983-10       Impact factor: 1.276

View more
  10 in total

1.  Western blot analysis of stray cat sera against Toxoplasma gondii and the diagnostic availability of monoclonal antibodies in sandwich-ELISA.

Authors:  W M Sohn; H W Nam
Journal:  Korean J Parasitol       Date:  1999-12       Impact factor: 1.341

2.  Protective effect of vaccination with a combination of recombinant surface antigen 1 and interleukin-12 against toxoplasmosis in mice.

Authors:  V Letscher-Bru; O Villard; B Risse; M Zauke; J P Klein; T T Kien
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

3.  Intranasal immunization with SAG1 protein of Toxoplasma gondii in association with cholera toxin dramatically reduces development of cerebral cysts after oral infection.

Authors:  N Debard; D Buzoni-Gatel; D Bout
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

4.  Early recognized antigen (p34) of Toxoplasma gondii after peroral ingestion of tissue cyst forming strain (Me49 strain) in mice.

Authors:  Y K Park; H W Nam
Journal:  Korean J Parasitol       Date:  1999-09       Impact factor: 1.341

5.  Immunity against Yersinia enterocolitica by vaccination with Yersinia HSP60 immunostimulating complexes or Yersinia HSP60 plus interleukin-12.

Authors:  A Noll
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

6.  Immunization of BALB/c mice with killed Neospora caninum tachyzoite antigen induces a type 2 immune response and exacerbates encephalitis and neurological disease.

Authors:  T V Baszler; T F McElwain; B A Mathison
Journal:  Clin Diagn Lab Immunol       Date:  2000-11

7.  Nonionic block copolymers potentiate activities of drugs for treatment of infections with Toxoplasma gondii.

Authors:  F G Araujo; T Slifer
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

8.  Intranasal immunisation with recombinant Toxoplasma gondii actin partly protects mice against toxoplasmosis.

Authors:  Li-Tian Yin; Hai-Xia Hao; Hai-Long Wang; Jian-Hong Zhang; Xiao-Li Meng; Guo-Rong Yin
Journal:  PLoS One       Date:  2013-12-27       Impact factor: 3.240

9.  Partial protective effect of intranasal immunization with recombinant Toxoplasma gondii rhoptry protein 17 against toxoplasmosis in mice.

Authors:  Hai-Long Wang; Tie-E Zhang; Li-Tian Yin; Min Pang; Li Guan; Hong-Li Liu; Jian-Hong Zhang; Xiao-Li Meng; Ji-Zhong Bai; Guo-Ping Zheng; Guo-Rong Yin
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

10.  Compound DNA vaccine encoding SAG1/ SAG3 with A2/B subunit of cholera toxin as a genetic adjuvant protects BALB/c mice against Toxoplasma gondii.

Authors:  Hua Cong; Min Zhang; Qing Xin; Zhiyu Wang; Ying Li; Qunli Zhao; Huaiyu Zhou; Shenyi He
Journal:  Parasit Vectors       Date:  2013-03-13       Impact factor: 3.876

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.